Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis.
about
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature reviewGraft versus host disease: New insights into A2A receptor agonist therapyA2aR antagonists: Next generation checkpoint blockade for cancer immunotherapyAdenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Adenosine A(3) receptors regulate heart rate, motor activity and body temperature.High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell populationMethotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis.Methotrexate in atherogenesis and cholesterol metabolismA highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2.Adenosine A(2A) receptor ligation inhibits osteoclast formation.Adenosine A2A receptor activation prevents wear particle-induced osteolysisInvolvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammationCentral Nervous System Injury - A Newly Observed Bystander Effect of RadiationFructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway.Regulation of inflammation by adenosine.Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease.A Standardized Chemically Modified Curcuma longa Extract Modulates IRAK-MAPK Signaling in Inflammation and Potentiates Cytotoxicity.Adenosine receptor agonists for promotion of dermal wound healing.Adenosine receptor targeting in health and disease.The use of methotrexate in dermatology: a review.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.Treatment of psoriatic arthritis with traditional DMARD's and novel therapies: approaches and recommendations.Adenosine A(2A) agonist and A(2B) antagonist mediate an inhibition of inflammation-induced contractile disturbance of a rat gastrointestinal preparation.Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism.Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.
P2860
Q24651475-6A148F0E-962C-4610-845F-466EB7EE5129Q26995202-9B61C14B-C6CA-4EBB-9D01-78A31373FE97Q28080809-A4F86047-CDCB-4FFB-81AF-1D0BA35E4D05Q28087576-BA5EEB18-C5E0-464B-8F30-FC7C532B2298Q33615249-D281B85B-9DC4-407C-90E6-56B846AC7F45Q33905910-CE8CC811-E287-450D-BA8A-81AD8C23AD87Q33931235-01255C9B-88B8-4684-A95C-6656084B99C5Q34292553-55AC096B-52E5-45D2-8561-2E495685D716Q34757801-4EA8A872-03E3-4A3E-8F8F-9A2A97A156C2Q35093044-6DDF69ED-E07F-48B9-9A37-7DF0742ADB96Q35410561-8694AD9C-DCD4-4D70-A730-F3355A870CBCQ35951939-8A01857C-ED97-45EB-821D-F244A185689CQ36067491-C2C2C419-15DE-440A-BF29-ACA280E497A2Q36090483-948B6093-F060-4348-887D-407F1D81AEE6Q36150038-1CFD541F-CE07-4140-B7A6-B6A3E5493C77Q36174658-A1AFC898-81BC-49BB-B2C2-0E2A61F2875AQ36746981-EF5E559C-30CB-4E21-92D8-56BC32403DBFQ36907484-BB6DB3E1-DFCF-4AC0-9B8F-4B02829B65D4Q37122453-B8F03AC7-E227-4674-A8EA-02C42C0CFBE4Q37165218-D4EF8334-B8A3-4776-8068-1528320A5C20Q37948081-233CB517-C61B-4F50-80A2-6FC6283AEA9DQ37981730-0F8ECA6A-B6AF-43A6-BC1B-A77E9632E10EQ38238947-2EB4508B-5921-487A-9437-C98B99D151DBQ38991972-C4939FAD-5BA9-4A9C-BDE3-D4D7B8133D2AQ39003610-A2CE85E9-2F18-4118-9A57-A93D56B3E3C4Q39600697-DB51BA10-5946-450C-BFBA-E516C314A17BQ40471318-FEDF1FD3-8293-4085-A518-FD3B998F881EQ54334590-3D612647-096A-481A-BBDD-247E8F867420
P2860
Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Suppression of inflammation by ...... lycollate-induced peritonitis.
@ast
Suppression of inflammation by ...... lycollate-induced peritonitis.
@en
Suppression of inflammation by ...... lycollate-induced peritonitis.
@nl
type
label
Suppression of inflammation by ...... lycollate-induced peritonitis.
@ast
Suppression of inflammation by ...... lycollate-induced peritonitis.
@en
Suppression of inflammation by ...... lycollate-induced peritonitis.
@nl
prefLabel
Suppression of inflammation by ...... lycollate-induced peritonitis.
@ast
Suppression of inflammation by ...... lycollate-induced peritonitis.
@en
Suppression of inflammation by ...... lycollate-induced peritonitis.
@nl
P2860
P356
P1476
Suppression of inflammation by ...... glycollate-induced peritonitis
@en
P2093
Avani Desai
P2860
P2888
P356
10.1186/AR1914
P577
2006-03-06T00:00:00Z
P5875
P6179
1025599871